HOUSE_OVERSIGHT_024851.jpg

1.44 MB

Extraction Summary

1
People
3
Organizations
1
Locations
0
Events
1
Relationships
2
Quotes

Document Information

Type: Financial research report / market analysis
File Size: 1.44 MB
Summary

This document is page 35 of a financial research report produced by Cowen on February 25, 2019, analyzing the U.S. CBD market, specifically focusing on 'Topicals.' The report projects the topical CBD market to grow to $1.5 billion by 2020. The document bears a 'HOUSE_OVERSIGHT_024851' Bates stamp, indicating it was obtained during a House Oversight Committee investigation, though the content of this specific page is purely financial market analysis and does not explicitly mention Jeffrey Epstein.

People (1)

Name Role Context
Michael Cella Recipient
Email address (michael.cella@cowen.com) listed in the sidebar watermark as the intended recipient of the report.

Organizations (3)

Locations (1)

Location Context

Relationships (1)

Michael Cella Employment/Affiliation Cowen
Email address michael.cella@cowen.com found in watermark.

Key Quotes (2)

"Over the next two years, we expect the topical CBD market to grow to $1.5 bn"
Source
HOUSE_OVERSIGHT_024851.jpg
Quote #1
"We estimate that in 2018, the total addressable U.S. topical market, which includes both OTC and rx offerings was ~$12.8 bn."
Source
HOUSE_OVERSIGHT_024851.jpg
Quote #2

Full Extracted Text

Complete text extracted from the document (2,434 characters)

COWEN
COLLABORATIVE INSIGHTS
February 25, 2019
Topicals
Outside of nutraceuticals, we expect the topical CBD market to provide the largest contribution to industry sales. We believe the non-ingestible nature of the product makes it more attractive to consumers looking to experiment in CBD and can provide a source of trial into the category. While the CBD market clearly needs more clinical research into the benefits of the cannabinoid, it has been suggested that two of the primary benefits are anti-inflammation and muscle recovery, which can cater to a large and diverse consumer base.
Over the next two years, we expect the topical CBD market to grow to $1.5 bn (almost $1 bn less than our outlook for nutraceuticals). We estimate that in 2018, the total addressable U.S. topical market, which includes both OTC and rx offerings was ~$12.8 bn. If we assume no growth in the category base, a $1.5 bn CBD category by 2020 would imply a ~12% share of the market, the largest market share among all of the categories analyzed, excluding nutraceuticals.
Figure 48 U.S. Topical Category Generates ~$13 BN In Revenue
U.S. Addressable Topical Market ($ in bn)
[Chart showing bars for 2018, 2019E, 2020E at values $12.8, $12.8, $12.8]
Source: Company Reports and Cowen and Company
Figure 49 We Believe CBD Topicals Could Be A $1.5 BN Market in 2 Years
U.S. CBD Topicals ($ in mm)
[Chart showing bars for 2018 ($500), 2019E ($1,000), 2020E ($1,500)]
Source: Cowen and Company
Our below scenario analysis provides a wider incremental range of market share outcomes relative to other categories. We can see that every 5 pts of market share capture is worth over $600 mm in revenues. While our analysis contemplates a 2% share of the topical market, we believe that this is unlikely and view the floor at ~7%, which would imply almost $900 mm in revenues by 2020. Given the number of companies providing topical solutions, coupled with what we expect to be robust consumer demand, a market share between 12-17% is not unrealistic.
Figure 50 Topicals Expected To Be a Major Contributor to CBD
2020 Market Share Scenario Analysis
Market Share | 2% | 7% | 12% | 17% | 22%
Absolute Sales ($ in mm) | $220 | $860 | $1,500 | $2,140 | $2,780
Source: Cowen and Company
[Sidebar Text]: This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited.
COWEN.COM
35
HOUSE_OVERSIGHT_024851

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document